Publications by authors named "Jon Giles"

Claim this Profile
T
Tapering in Rheumatoid Arthritis: A Path to Predict Flares.
Elise van Mulligen, Jon T Giles, Angelique E A M Weel

Arthritis Rheumatol· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Performance of the new PREVENT score for indicating subclinical atherosclerosis in rheumatoid arthritis.
J Alex B Gibbons, Joan M Bathon, Jon T Giles

Rheumatology (Oxford)· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Rationale and design of the rheumatoid arthritis non-responders to treatment (RANT) study: Use of a bioinformatics platform and "decentralized" clinical recruitment design.
Gregory C McDermott, Mary Jeffway, Thany Seyok, Harrison Zhang, Elena Myasoedova, Jon Giles

Contemp Clin Trials· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
ERS/EULAR clinical practice guidelines for connective tissue disease-associated interstitial lung diseaseDeveloped by the task force for connective tissue disease-associated interstitial lung disease of the European Respiratory Society (ERS) and the European Alliance of Associations for Rheumatology (EULAR)Endorsed by the European Reference Network on rare respiratory diseases (ERN-LUNG).
Katerina M Antoniou, Oliver Distler, Ana-Maria Gheorghiu, Catharina C Moor, Jens Vikse, Jon T Giles

Eur Respir J· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
ERS/EULAR clinical practice guidelines for connective tissue diseases associated interstitial lung disease.
Katerina M Antoniou, Oliver Distler, Ana-Maria Gheorghiu, Catharina C Moor, Jens Vikse, Jon T Giles

Ann Rheum Dis· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Use of statins and its association with major adverse cardiovascular events with tofacitinib vs TNF inhibitors in patients with rheumatoid arthritis with and without atherosclerotic cardiovascular disease.
Jon T Giles, Christina Charles-Schoeman, Maya H Buch, Maxime Dougados, Zoltán Szekanecz

Ann Rheum Dis· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Immunomodulatory Nanoparticles Enable Combination Therapies To Enhance Disease Prevention and Flare Control in Rheumatoid Arthritis.
Wade T Johnson, Elizabeth L Wilkinson, Neha Iyer, Maksim Dolmat, Miriam Bollmann, Jon T Giles

ACS Cent Sci· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Association of the multi-biomarker disease activity score with arterial 18-fluorodeoxyglucose uptake in rheumatoid arthritis.
Jon T Giles, Daniel H Solomon, Katherine P Liao, Pamela M Rist, Zahi A Fayad

Rheumatology (Oxford)· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Genomic and Serological Rheumatoid Arthritis Biomarkers, Promoter Variant, and Interstitial Lung Abnormalities.
John S Kim, Kathryn F Flack, Vidhi Malik, Ani Manichaikul, Saori Sakaue, Jon T Giles

Ann Am Thorac Soc· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Returning Incidental Research Findings From F-Fluorodeoxyglucose-Positron Emission Tomography/Computed Tomography to Participants: A Survey of Investigators From a Clinical Trial of Rheumatoid Arthritis.
Jane S Kang, Howard F Andrews, Jon T Giles, Katherine P Liao, Daniel H Solomon

Arthritis Care Res (Hoboken)· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effect of biologic agents and inflammation on lipid levels and cardiovascular risk in rheumatoid arthritis patients.
Dimitrios A Pappas, George Reed, Kevin Kane, Jeffrey R Curtis, Christina Charles-Schoeman, Jon T Giles

Semin Arthritis Rheum· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Use of methotrexate and TNF inhibitors in patients with rheumatoid arthritis-associated interstitial lung disease: a survey of rheumatologists.
Elizabeth Park, Rabia Iqbal, Jon T Giles, Elana J Bernstein

Clin Rheumatol· September 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of RA treatment strategies on lipids and vascular inflammation in rheumatoid arthritis: a secondary analysis of the TARGET randomized active comparator trial.
Katherine P Liao, Pamela Rist, Jon Giles, Leah Santacroce, Margery A Connelly

Arthritis Res Ther· June 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Associations of galectin-3 levels with measures of vascular disease in patients with rheumatoid arthritis.
Amanda Nussdorf, Elizabeth Park, Isabelle Amigues, Laura Geraldino-Pardilla, Sabahat Bokhari, Jon T Giles

Semin Arthritis Rheum· April 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Risk of extended major adverse cardiovascular event endpoints with tofacitinib versus TNF inhibitors in patients with rheumatoid arthritis: a post hoc analysis of a phase 3b/4 randomised safety study.
Maya H Buch, Deepak L Bhatt, Christina Charles-Schoeman, Jon T Giles, Ted Mikuls

RMD Open· April 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The monocyte cell surface is a unique site of autoantigen generation in rheumatoid arthritis.
Mekha A Thomas, Pooja Naik, Hong Wang, Jon T Giles, Alexander A Girgis

Proc Natl Acad Sci U S A· April 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Lower body mass and lower adiposity are associated with differential responses to two treatment strategies for rheumatoid arthritis.
Joshua F Baker, James R ODell, Bryant R England, Jon T Giles, Jefferey A Newcomb

Ann Rheum Dis· March 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Improvement in joint inflammation is accompanied by reduction in arterial inflammation: Tocilizumab in rheumatoid arthritis.
Hadil Zureigat, Giovanni Civieri, Shady Abohashem, Michael T Osborne, Daniel H Solomon, Jon T Giles

J Nucl Cardiol· March 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Biomarkers of Cardiovascular Risk in Patients With Rheumatoid Arthritis: Results From the TARGET Trial.
Daniel H Solomon, Olga Demler, Pamela M Rist, Leah Santacroce, Ahmed Tawakol, Jon T Giles

J Am Heart Assoc· March 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of Upadacitinib on Laboratory Parameters and Related Adverse Events in Patients with RA: Integrated Data Up to 6.5 Years.
Christina Charles-Schoeman, Jon T Giles, Nancy E Lane, Ernest Choy, Daniel E Furst

Rheumatol Ther· February 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
J
JAK inhibitors and black box warnings: what is the future for JAK inhibitors?
Kate Tokareva, Pankti Reid, Victor Yang, David Liew, Alexander C Peterson, Jon Giles

Expert Rev Clin Immunol· November 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Identification of novel biomarkers for the prediction of subclinical coronary artery atherosclerosis in patients with rheumatoid arthritis: an exploratory analysis.
Joan M Bathon, Michael Centola, Xiaoqian Liu, Zhicheng Jin, Weihua Ji, Jon T Giles

Arthritis Res Ther· October 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Shared inflammatory pathways of rheumatoid arthritis and atherosclerotic cardiovascular disease.
Brittany N Weber, Jon T Giles, Katherine P Liao

Nat Rev Rheumatol· July 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Left ventricular remodeling in rheumatoid arthritis patients without clinical heart failure.
Elizabeth Park, Kazato Ito, Christopher Depender, Jon T Giles, Joan Bathon

Arthritis Res Ther· July 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of cardiovascular risk enrichment on incidence of major adverse cardiovascular events in the tofacitinib rheumatoid arthritis clinical programme.
Maxime Dougados, Christina Charles-Schoeman, Zoltán Szekanecz, Jon T Giles, Steven R Ytterberg

Ann Rheum Dis· April 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis